Compound Y-909

Compound Y-909 is a component of Cenci Foundation Amnesiacs.

Uses

According to a leaked foundation document. Compound Y-909 was originally discovered by the late Dr Adam Hollister and became a critical component in the development of modern amnestic compounds.

9 Foundation Amnesiacs use the compound.

The inclusion of the Y-909 compound showed a marked increase in the stability and long-term effectiveness of the current Foundation amnestics. Overall, amnesics utilizing Y-909 break down 78% slower than their standard counterparts in cold storage, and 52% slower than their standard counterparts at room temperature. Additionally, individuals administered an amnestic regimen utilising Y-909 showed a marked increase in suggestibility, memory clearance, and a significant decrease in additional side-effects (such as nausea, vomiting, bowel distress, blurred vision, headaches, insomnia, heart damage, and others). Individuals treated with these amnesiacs expressed significantly fewer intrusive memories as those without Y-909, with some individuals exposed to experimental compounds expressing no intrusive memories whatsoever, even at the 5 and 10 year marks.

Due to the effectiveness of these treatments with the addition of Y-909, the future inclusion of this compound is essential to modern Foundation amnestic application. Reliance on the continued use of Y-909 necessitates its collection for the foreseeable future, as a synthetic version of the compound has not yet been discovered.

City-scale human testing of these amnesiacs was used during Project Nod in 2018

Collection

Compound Y-909 is an excretion of CF-3000

The excretions are collected using the 151-HOLLISTER ATZAK PROTOCOL